NASDAQ · HQY

HealthEquity, Inc.

$94.64 +$0.31 (+0.32%) 1D After hours
Charting by TradingView

Key Metrics

$7.89B
Market cap
34.18×
P/E · TTM
$1.34B
Revenue · TTM
$230.70M
Net income
EPS · TTM $2.61
Dividend yield —
Free cash flow $487.64M
Beta · 1Y 0.70
EBITDA · TTM $453.02M
Gross margin 70.7%

The Story So Far

LAST 6 MONTHS PRIMARY SOURCES ONLY
  • Jul 27
    Money has been moving out of its sector (Technology).

    Technology has run -4.1 points vs SPY over four weeks, ranking 8→2→11→7 of 11 sectors — this stock trades inside that current.

    RECEIPT: ROTATION MAP, LIVE ↗
  • Jul 16
    Money rotated out of high-beta cohorts market-wide.

    High-beta names lagged the blue-chips by 18.6 points over ten sessions around this date. Stocks in that cohort weren't falling alone — they fell together.

    RECEIPT: ROTATION GAUGE, LIVE

The story updates itself as events post · The wolf reports; you decide

Snapshot

Market cap$7.89B
Enterprise value$8.56B
Shares outstanding83.6M
52-wk range$72.76 – $105.96
Avg volume · 20D775.0K
Net cash −$677.29M
Book value / share$23.16
IndustryServices-Business Services, Nec
ExchangeNASDAQ
About HealthEquity, Inc.
IPO dateJul 31, 2014
Employees2814

HealthEquity Inc provides solutions that allow consumers to make healthcare saving and spending decisions. It provides payment processing services, personalized benefit information, the ability to earn wellness incentives, and investment advice to grow their tax-advantaged healthcare savings.

Wolf Grade COMING SOON

—

The wolf is in training. Composite grades vs sector — profitability, health, value, momentum — arrive with the percentile engine. Methodology will be public.

Valuation

P/E34.18
P/S5.90
P/FCF16.17
EV/EBITDA18.90
EV/Sales6.40
Graham №$36.87

Profitability

Gross 70.7%
Operating 22.4%
Net 17.3%
FCF 36.5%
ROE / ROIC 11.1% · 8.5%

Financial Health

Current ratio3.44
Quick ratio—
Debt / equity0.46
Debt / EBITDA 2.08
Net cash −$677.29M
Working capital$330.79M

Cash Flow · TTM

Operating CF $489.88M
Capex −$2.25M
Free cash flow $487.64M
Buybacks $363.50M
Dividends paid —
Shareholder yield 4.6%

Piotroski F-Score

8 / 9
Strong fundamentals · 8 of 9 signals passing

Altman Z-Score

4.7
Safe zone (> 2.99) · bankruptcy risk negligible

Graham Number vs Price

$36.87 vs $94.64
Trades 2.6× above classic defensive value — priced for growth
Fundamentals through 2026-04-30 · computed by TickerWolf from SEC filings